Evidence map›Paper›PMID 31220048›Full record

ArticleThe Pediatric infectious disease journal2019

Invasive Pneumococcal Infections in Children with Nephrotic Syndrome in Bangladesh.

Roly Malaker, Senjuti Saha, Mohammed Hanif, Asmnu Ahmed, Shampa Saha, Md Hasanuzzaman, Tarannum Khondakar, Maksuda Islam, Abdullah H Baqui, Mathuram Santosham and 3 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in The Pediatric infectious disease journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07497776 (Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07497776 phase4completedstarted 2024, after this paper: background citation

Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome

Ran2024Enrolled100Registered outcomes1Posted comparisons0ConditionsDyslipidaemiaArmsAtorvastatin
Open the trial in the graph
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Human vaccines & immunotherapeutics · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Roly MalakerFrom the Child Health Research Foundation, Department of Microbiology, Dhaka Shishu Hospital, Dhaka, Bangladesh.
Senjuti SahaFrom the Child Health Research Foundation, Department of Microbiology, Dhaka Shishu Hospital, Dhaka, Bangladesh.
Mohammed HanifBangladesh Institute of Child Health, Dhaka Shishu Hospital, Dhaka, Bangladesh.
Asmnu AhmedFrom the Child Health Research Foundation, Department of Microbiology, Dhaka Shishu Hospital, Dhaka, Bangladesh.
Shampa SahaFrom the Child Health Research Foundation, Department of Microbiology, Dhaka Shishu Hospital, Dhaka, Bangladesh.
Md HasanuzzamanFrom the Child Health Research Foundation, Department of Microbiology, Dhaka Shishu Hospital, Dhaka, Bangladesh.
Tarannum KhondakarBangladesh Institute of Child Health, Dhaka Shishu Hospital, Dhaka, Bangladesh.
Maksuda IslamFrom the Child Health Research Foundation, Department of Microbiology, Dhaka Shishu Hospital, Dhaka, Bangladesh.
Abdullah H BaquiDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Mathuram SantoshamDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Gary L DarmstadtDepartment of Pediatrics, Stanford University School of Medicine, Stanford, California.
Cynthia G WhitneyCenters for Disease Control and Prevention, Atlanta, Georgia.
Samir K SahaFrom the Child Health Research Foundation, Department of Microbiology, Dhaka Shishu Hospital, Dhaka, Bangladesh.
Dhaka Shishu Hospital · BDChild Health Research Foundation · BDJohns Hopkins University · USCenters for Disease Control and Prevention · USStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionChildren with nephrotic syndrome are susceptible to invasive bacterial infections. In this study, we aimed to: (1) determine the pathogens associated with infections in children with nephrotic syndrome and (2) describe antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae to guide evidence-based treatment and prevention policies.

methodsFrom June 2013 to March 2015, we collected blood and/or ascitic fluid from children hospitalized with nephrotic syndrome and suspected bacterial disease in the largest pediatric hospital of Bangladesh. We cultured all samples and performed polymerase chain reaction (PCR) and immunochromatographic test on ascitic fluid for detection of S. pneumoniae. Pneumococcal isolates were tested for antibiotic susceptibility using disc diffusion and serotyped using Quellung reaction and PCR.

resultsWe identified 1342 children hospitalized with nephrotic syndrome. Among them, 608 children had suspected bacterial disease from whom blood and/or ascitic fluid were collected. A pathogen was identified in 8% (48/608) of cases, 94% (45/48) of which were S. pneumoniae. Most (73%, 33/45) pneumococcal infections were identified through culture of blood and ascitic fluid and 27% (12/45) through immunochromatographic test and PCR of ascitic fluid. In total, 24 different pneumococcal serotypes were detected; 51% are covered by PCV10 (+6A), 53% by PCV13 and 60% by PPSV23. All pneumococcal isolates were susceptible to penicillin.

conclusionsBecause S. pneumoniae was the primary cause of invasive infections, pneumococcal vaccines may be considered as a preventive intervention in children with nephrotic syndrome. Additionally, penicillin can be used to prevent and treat pneumococcal infections in children with nephrotic syndrome in Bangladesh.

Indexed as

AdolescentAnti-Bacterial AgentsBangladeshChildChild, PreschoolFemaleHumansImmunoassayInfantInfant, NewbornMaleMicrobial Sensitivity TestsNephrotic SyndromePneumococcal InfectionsPolymerase Chain ReactionReproducibility of ResultsAnti-Bacterial Agents

Identifiers

PMID31220048
OpenAlexW2950172961

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.